吉西他滨联合顺铂化疗方案治疗晚期非小细胞肺癌的近期疗效观察被引量：2

下载PDF

导出

摘要目的:评价吉西他滨联合顺铂化疗方案治疗晚期非小细胞肺癌的近期疗效和不良反应。方法:晚期非小细胞肺癌患者48例,给予GP联合方案化疗。结果:总有效率60.41%,主要不良反应为骨髓抑制和胃肠道反应。结论:吉西他滨联合顺铂化疗方案治疗晚期非小细胞肺癌有较好的疗效,不良反应轻,值得临床研究和推广。

作者李忠杨志胤欧贵雪

机构地区福建医科大学附属医院闽东医院

出处《中国社区医师（医学专业）》 2011年第14期130-130,共1页

关键词非小细胞肺癌化疗吉西他滨顺铂

参考文献4

1Raez L E,Lilenbaum R.New developments in chem othe rapy for advanced non-small cell lung cancer.Curr Opin Oncol,2006,18(2):156-161.
2Einhorn L H.first-line chem othe rapy fo non-small-cell lung cancer is there a superior regimen based on histology.J Clin Oncol,2008,26(21):3485-3486.
3邓立春,茅卫东,许晨.GP方案和MVP方案治疗晚期非小细胞肺癌的比较研究[J].临床肿瘤学杂志,2004,9(3):305-306. 被引量：2
4Manegold C,Zatloukal P,Krejcy K,et al.Gemcitabine in non-small-cell lung cancer.Invest New Drugs,2000,18(1):29-42.

1Gztzemeie U,Shepherd FA,Le Chevalier T,et al.Activity of gemcitabine in patients with Non-small cell lung cancer:A multicentre,extended phase Ⅱ study[J].Eur J Cancer,1996,32A:243.
2Boudewijin JM,Braskhuis GA,Jan BV,et al.Preclinical in vivo activity gemcitabine against human head and neck cancer[J].Cancer Res,1991,51(1):211.
3Crino L,Scagliotti G,Marangolo M,et al.Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer:a phase Ⅱ study[J].J Clin Oncol,1997,15(1):297.
4Rosell R,Tonuto M,Sandler A,et al.The activity of gemcitabine plus cisplatin in randomized trials in untreated patients with advanced non-small-cell lung cancer[J].J Semin Oncol,1998,25(4):27.
5Paul A,Bunn J.Triplet chemotherapy with gemcitabine,a platinum and a third agent in the treatment of advanced non-small-cell lung cancer[J].J Semin Oncol,1999,26(1):25.
6Anderson H,lund B.Single-agent activity of weekly gemcitabine in advanced non-samll-cell lung cancer:a phase Ⅱ study[J].J Clin Oncol,1994,12:1821.
7王奇璐.肺癌化疗现状与进展[J].齐鲁肿瘤杂志,1998,5(3):163-165. 被引量：5
8张湘茹,孙燕,冯奉仪,徐兵河,张弘纲,周立强,李青,张频,何小慧,王宏羽.丝裂霉素、长春花碱酰胺、顺铂联合治疗晚期非小细胞肺癌108例[J].中华肿瘤杂志,1999,21(3):220-223. 被引量：34
9徐建芳,周彩存.吉西他滨与顺铂联合治疗晚期非小细胞肺癌的临床疗效[J].中国临床药学杂志,2001,10(1):4-6. 被引量：14